Medilife Innovations

Venus Versa™ is cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions, benign cutaneous vascular lesions, removal of unwanted hair, treatment of acne vulgaris, dermatological procedures requiring ablation and resurfacing of the skin, and non-invasive treatment of moderate to severe wrinkles and rhytides. Venus Versa™ is licensed by Health Canada for the treatment of benign pigmented epidermal and cutaneous lesions, benign cutaneous vascular lesions, removal of unwanted hair, treatment of acne vulgaris, dermatological procedures requiring ablation and resurfacing of the skin, non-invasive treatment of moderate to severe wrinkles and rhytides, and body contouring via skin tightening, circumferential reduction, and cellulite reduction.

Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides and temporary reduction in the appearance of cellulite, and licensed by Health Canada for the non-invasive treatment of skin tightening, temporary circumferential reduction, cellulite reduction, and wrinkle reduction.

Venus Viva™ is cleared by the FDA and licensed by Health Canada for dermatological procedures requiring ablation and resurfacing of the skin. The DiamondPolar™ applicator is licensed by Health Canada for the non-invasive treatment of moderate to severe facial wrinkles and rhytides.

Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and licensed by Health Canada for the non-invasive treatment of cellulite reduction, skin tightening, and temporary reduction in the appearance of stretch marks.

Venus Freeze™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and licensed by Health Canada for the non-invasive treatment of cellulite reduction, skin tightening, and temporary reduction in the appearance of stretch marks.

Venus Fiore™ has been launched in India, Hong Kong, and other Asian countries, and is undergoing regulatory processes in Europe and North America. It is designed as a unique solution for feminine health with three applicators to address internal vaginal health restoration, labia skin tightening, and mons pubis reduction.

Venus Swan™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and licensed by Health Canada for the non-invasive treatment of cellulite reduction, skin tightening, and temporary reduction in the appearance of stretch marks.